authorization – Page 2

FDA Limits Use of Invivyd’s COVID-19 Prophylactic as New Variants Dominate

1 year ago talkbio0Tagged authorization, COVID19 (disease), Emergency Situation, Immunocompromised Host, Invivyd, Pemgarda, United States Food and Drug Administration, Variant

Invivyd, COVID-19, Pemgarda, Emergency Use Authorization, FDA, Immunocompromised, Variants

FDA Approves Updated COVID-19 Vaccines from Pfizer and Moderna for Enhanced Protection

1 year ago talkbio0Tagged Approved, authorization, COVID19 (disease), Emergency Situation, Guidelines, JN.1, KP.2, Lineage, Moderna, Pfizer, Pfizer/, RNA, Messenger, United States Food and Drug Administration, Vaccination, Vaccines, Variant

COVID-19 vaccines, FDA approval, mRNA vaccines, Pfizer, Moderna, updated vaccines, KP.2 variant, JN.1 lineage, emergency use authorization, vaccination guidelines.

Biogen and Ionis’ ALS Treatment Qalsody Receives European Commission Approval

2 years ago talkbio0Tagged Amyotrophic Lateral Sclerosis, authorization, Biogen, Clinical Trials, Commission, European (ethnic group), Ionis, Qalsody, SOD1, SOD1-ALS

Biogen, Ionis, Qalsody, ALS, European Commission, Marketing Authorization, Rare Disease, SOD1-ALS, Neurofilament, Clinical Trials

Europe Temporarily Halts AstraZeneca’s Vaxzevria COVID-19 Vaccine on Company’s Request

2 years ago talkbio0Tagged AstraZeneca, authorization, concerns, COVID19 (disease), Europe, European Medicines Agency, Pharmacovigilance, Safety, Suspensions, Vaccines, Vaxzevria

AstraZeneca, Vaxzevria, COVID-19 vaccine, marketing authorization, suspension, Europe, European Medicines Agency (EMA), pharmacovigilance, safety concerns.